InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $3.600 0.16 (4.65%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,160 Application for quotation of securities - 4DX 17 Sep 2025 11:18AM $1.895 $3.600 risen by 89.97%
$2,160 Application for quotation of securities - 4DX 17 Sep 2025 11:14AM $1.895 $3.600 risen by 89.97%
$2,160 Investor Webinar - Dr Kyle Hogarth 16 Sep 2025 3:37PM $1.780 $3.600 risen by 102.25%
$2,160 Updated Top 20 Option Holders & Distribution Schedule 12 Sep 2025 11:03AM $1.940 $3.600 risen by 85.57%
$2,160 Supplementary announcement - 4DX agreements 12 Sep 2025 9:17AM $1.890 $3.600 risen by 90.48%
$2,160 Top 20 Option Holders & Distribution Schedule 11 Sep 2025 12:00PM $1.625 $3.600 risen by 121.54%
$2,160 Application for quotation of securities - 4DX 11 Sep 2025 11:53AM $1.625 $3.600 risen by 121.54%
$2,160 Notification regarding unquoted securities - 4DX 11 Sep 2025 11:40AM $1.610 $3.600 risen by 123.60%
$2,160 Application for quotation of securities - 4DX 11 Sep 2025 11:36AM $1.610 $3.600 risen by 123.60%
$2,160 Cleansing Notice 9 Sep 2025 5:06PM $1.675 $3.600 risen by 114.93%
$2,160 Application for quotation of securities - 4DX 9 Sep 2025 4:56PM $1.675 $3.600 risen by 114.93%
$2,160 Notification regarding unquoted securities - 4DX 9 Sep 2025 4:41PM $1.675 $3.600 risen by 114.93%
$2,160 Notification regarding unquoted securities - 4DX 9 Sep 2025 12:59PM $1.885 $3.600 risen by 90.98%
$2,160 Application for quotation of securities - 4DX 9 Sep 2025 12:55PM $1.885 $3.600 risen by 90.98%
$2,160 4DX signs agreements with national lung screening sites 8 Sep 2025 8:38AM $1.545 $3.600 risen by 133.01%
$2,160 S&P DJI Announces September 2025 Quarterly Rebalance 5 Sep 2025 5:08PM $1.545 $3.600 risen by 133.01%
$2,160 Notification regarding unquoted securities - 4DX 4 Sep 2025 2:37PM $1.405 $3.600 risen by 156.23%
$2,160 Application for quotation of securities - 4DX 4 Sep 2025 2:32PM $1.405 $3.600 risen by 156.23%
$2,160 Notification of Date of 2025 AGM 4 Sep 2025 9:52AM $1.155 $3.600 risen by 211.69%
$2,160 Notification of upcoming expiry of Listed Options 3 Sep 2025 3:18PM $1.080 $3.600 risen by 233.33%
$2,160 4DMedical gains U.S. CMS reimbursement for CTVQ 3 Sep 2025 8:30AM $0.770 $3.600 risen by 367.53%
$2,160 4DMedical receives $6.0m R&D Tax Incentive 2 Sep 2025 9:38AM $0.775 $3.600 risen by 364.52%
$2,160 4DMedical receives $6.0m R&D Tax Incentive 2 Sep 2025 9:38AM $0.775 $3.600 risen by 364.52%
$2,160 4DMedical receives FDA clearance for CTVQ 1 Sep 2025 8:26AM $0.570 $3.600 risen by 531.58%
$2,160 4DMedical receives FDA clearance for CTVQ 1 Sep 2025 8:26AM $0.570 $3.600 risen by 531.58%

151 - 175 of 596 results

Page 7 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.